Found: 16
Select item for more details and to access through your institution.
Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 5, p. 1, doi. 10.1038/s41419-021-03776-8
- By:
- Publication type:
- Article
Understanding the Mechanism of Action of NAI-112, a Lanthipeptide with Potent Antinociceptive Activity.
- Published in:
- Molecules, 2021, v. 26, n. 22, p. 6764, doi. 10.3390/molecules26226764
- By:
- Publication type:
- Article
Cycloalkyl Indole-2-Carboxylates as Useful Tools for Mapping the "North-Eastern" Region of the Glycine Binding Site Associated with the NMDA Receptor.
- Published in:
- Archiv der Pharmazie, 1999, v. 332, n. 3, p. 73, doi. 10.1002/(SICI)1521-4184(19993)332:3<73::AID-ARDP73>3.0.CO;2-5
- By:
- Publication type:
- Article
Galantamine potentiates the neuroprotective effect of memantine against NMDA‐induced excitotoxicity.
- Published in:
- Brain & Behavior, 2013, v. 3, n. 2, p. 67, doi. 10.1002/brb3.118
- By:
- Publication type:
- Article
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
- Published in:
- Psychopharmacology, 2005, v. 179, n. 1, p. 207, doi. 10.1007/s00213-005-2143-4
- By:
- Publication type:
- Article
Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients.
- Published in:
- Metabolomics, 2019, v. 15, n. 5, p. N.PAG, doi. 10.1007/s11306-019-1536-z
- By:
- Publication type:
- Article
Therapeutic potential of galantamine and memantine combination for Alzheimer's disease in scopolamine-induced amnesia models
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056870
- By:
- Publication type:
- Article
Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies.
- Published in:
- Proteomics, 2005, v. 5, n. 17, p. 4558, doi. 10.1002/pmic.200402088
- By:
- Publication type:
- Article
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's Disease.
- Published in:
- Scientific Reports, 2016, p. 33172, doi. 10.1038/srep33172
- By:
- Publication type:
- Article
The microvascular system in ischemic cortical lesions.
- Published in:
- Acta Neuropathologica, 1996, v. 92, n. 1, p. 56, doi. 10.1007/s004010050489
- By:
- Publication type:
- Article
Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 8, p. 1340, doi. 10.3390/jpm12081340
- By:
- Publication type:
- Article
Corrigendum: A catalytically silent FAAH-1 variant drives anandamide transport in neurons.
- Published in:
- Nature Neuroscience, 2013, v. 16, n. 12, p. 1907, doi. 10.1038/nn1213-1907a
- By:
- Publication type:
- Article
A catalytically silent FAAH-1 variant drives anandamide transport in neurons.
- Published in:
- Nature Neuroscience, 2012, v. 15, n. 1, p. 64, doi. 10.1038/nn.2986
- By:
- Publication type:
- Article
novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 6, p. 839, doi. 10.1093/hmg/ddab251
- By:
- Publication type:
- Article
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01449-1
- By:
- Publication type:
- Article